The World Health Organization (WHO) actively responds to anthrax epidemic in the Democratic Republic of the Congo (DRC) ...

We have identified an optimized peptide inhibitor that can be used to develop potent anthrax toxin therapeutics. Anthrax toxin, an essential virulence factor of Bacillus anthracis, elicits many of the ...

The global threat posed by multidrug-resistant bacteria, particularly those producing KPC-2 carbapenemases, has compromised the effectiveness of carbapenems, the last-resort antibiotics. To address ...

Although cases of inhalational anthrax may be controlled by antibiotics, the treatment regimen has to be followed continuously for 60 days to ensure any residual spores are eliminated.

Prior to the advent of antibiotics, anthrax was treated by passive immunization with animal antisera. [2, 14] This practice indicated an important role for antibodies in protecting against the ...